Author Archive | Clifford

Recession….What Recession? CEO Pay Continues to Skyrocket

Massive numbers of public and private employees have lost their jobs in the past five years.USunemployment still hovers around 8.0% but yet corporate profits have been hitting historical highs for the past two years. And, not surprisingly, CEOs are milking those profits for as much as they can get. To be fair, some public companies […]

Continue Reading

BioJobBlog Domain Name Held Hostage By GoDaddy.com

Some of you may be wondering what happened to my blog posts on blog notions.  I apologize for not providing new content but due to an internal error committed by service representatives at GoDaddy.com the domain name biojobblog.com that I owned for 7 years was purchased by a new registrant (who I believe contacted me […]

Continue Reading

Abbott Slashes 700 Jobs From Its Medical Devices and Diagnostics Unit

Chicago-based Abbott Laboratories today announced that it would lay off 700 employees from its medical devices and diagnostics division as part of an ongoing restructuring effort. Most of the layoffs will take place in the Chicago area and affect employees that manufacture the company’s cardiovascular stents and diagnostic tests. According to a company spokesperson approximately […]

Continue Reading

Chewing Gum and Ear Infections

While I consider myself to be an informed microbiologist, I had never heard the assertion that chewing gum may reduce the incidence of ear infections among children. As we all know from our primary and secondary school educations, chewing gum is frowned upon and in the old days landed some of us detention! Therefore, a piece in […]

Continue Reading

The Impact of Consolidation on Pharmaceutical R&D

Over the past 10 years or so there has been an enormous amount of consolidation in the life science industry. While this activity has been very good for shareholders, it has had a devastating effort on pharmaceutical R&D says John  LaMattina PhD, a chemist, blogger, author and former President of Pfizer Global R&D. In his […]

Continue Reading

Biosimilar Regulatory Guidance is Imminent

Late last week, Janet Woodcock, head of the US Food and Drug Administration’s (FDA) Center for Drug Evaluation (CDER) made public comments which suggested that the long awaited guidance for approval of biosimilar products in the US was complete and likely to be issued by the end of this year. According to the Pharmalot Blog, another […]

Continue Reading

Combining Business and Biology to Increase Career Options

If you received your bachelors degree in biology or a related field, there is a good chance that you are having difficulty finding a job. The lack of an advanced degree in the life sciences can hurt your chances of securing a job mainly because most of life sciences jobs demand more education and experience […]

Continue Reading

The US Science Job Market: A Conundrum?

A recent report issued by the US Department of Commerce reported that job opportunities in science technology, engineering and math fields (STEM) are increasing in America. The report contends that over the past decade the number of people employed in STEM jobs has increased three times as much as the growth rate for non-STEM jobs […]

Continue Reading

The Hidden Costs Of Prescription Drug Development That Nobody Likes To Talk About!

Depending upon the source, the cost of bringing a new prescription drug to market these days ranges from roughly $1.2 to 1.5 billion. While there is no question that clinical studies represent the most costly aspect of getting new drugs approved, the hidden costs—mainly promotion and marketing—are what actually inflate the costs of new drug development. Not […]

Continue Reading